CoChat

Dasatinib

Kantarjian, Hagop, Jabbour, Elias, Grimley, Joanne, Kirkpatrick, Peter · 2006 · Nature Reviews Drug Discovery

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Overview

Integrity signals

Registry

Crossref · 10.1038/nrd2135

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 11 references

Cited by

Items 101–159 of 159

Metadata

Authors
Kantarjian, H., Jabbour, E., Grimley, J., & Kirkpatrick, P.
Affiliations
  • The University of Texas MD Anderson Cancer Center (US)
  • IQVIA (United States) (US)
Venue
Nature Reviews Drug Discovery
Published
2006-09
Volume
5
Issue
9
Pages
717-718
ISSN
  • 1474-1776 (ISSN-L)
  • 1474-1784
OpenAlex
W4247947439
Cited by
149
References
11
Citations by year
2026: 6 · 2025: 8 · 2024: 19 · 2023: 11 · 2022: 14 · 2021: 13 · 2020: 5 · 2019: 6 · 2018: 3 · 2017: 3 · 2016: 5 · 2015: 5 · 2014: 5 · 2013: 5 · 2012: 6
Type
other
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Reviews Drug Discovery (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
  • Health Sciences › Medicine › Hematology › Chronic Lymphocytic Leukemia Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Keywords
dasatinib, tyrosine kinase inhibitors, chronic myeloid leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemia, imatinib resistance, drug approval, BCR-ABL
MeSH terms
Dasatinib, Administration, Oral, Adult, Clinical Trials as Topic, Humans, Pyrimidines, Thiazoles, Molecular Structure, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Treatment Outcome, Drug Approval, Guideline Adherence, Protein Kinase Inhibitors, Precursor Cell Lymphoblastic Leukemia-Lymphoma

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.